Medicare Enrolled

Dr. Anita Pandey, M.D.

Hematology & Oncology · Rolling Meadows, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3701 ALGONQUIN RD STE 900, Rolling Meadows, IL 60008
8475770620
In practice since 2012 (13 years)
NPI: 1245580604 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pandey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pandey? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pandey

Dr. Anita Pandey is a hematology & oncology specialist in Rolling Meadows, IL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Pandey performed 51,284 Medicare services across 2,330 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pandey received a total of $8,546 from 68 pharmaceutical and/or device companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pandey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 20% volume in IL $8,546 industry payments

Medicare Practice Summary

Medicare Utilization ↗
51,284
Medicare services
Top 20% in IL for hematology & oncology
2,330
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,945 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Injectafer)
An intravenous injection of ferric carboxymaltose, an iron replacement medication.
23,250 $1 $2
Darbepoetin injection (Aranesp) for anemia
An injection of darbepoetin alfa used for non-end-stage renal disease purposes.
8,300 $2 $9
Anti-nausea injection (aprepitant) 6,110 $1 $4
Injection, granisetron, extended-release, 0.1 mg 6,100 $6 $10
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,432 $0 $2
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
1,174 $8 $55
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
777 $10 $65
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
489 $91 $290
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
425 $143 $335
Immunoglobulin level test
A blood test that measures the level of gammaglobulins, which are immune system proteins.
287 $9 $40
Carboplatin chemotherapy injection, 50 mg
Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection.
252 $2 $40
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
211 $12 $68
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
202 $108 $488
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
164 $13 $74
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
162 $24 $135
Iron level test 144 $6 $50
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
144 $9 $35
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
144 $66 $165
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
139 $6 $48
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
130 $13 $85
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
93 $16 $93
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
89 $23 $129
Magnesium sulfate injection, per 500 mg
An injection of magnesium sulfate administered in 500 mg increments.
88 $1 $6
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
82 $53 $230
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
82 $66 $190
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
78 $4 $20
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
74 $54 $249
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
64 $145 $426
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 62 $20 $200
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
58 $1 $6
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
46 $11 $65
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
44 $15 $80
Phosphate level test
A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong.
44 $5 $30
Immunologic analysis for detection of tumor antigen, quantitative; ca 125 44 $20 $134
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
42 $3 $10
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
34 $1 $12
Magnesium level test
A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess.
33 $7 $55
Carcinoembryonic antigen (CEA) level test
A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer.
31 $19 $100
New patient office visit, complex (60-74 min) 29 $184 $495
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
27 $109 $328
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
27 $2 $19
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
26 $99 $259
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
23 $129 $390
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
15 $9 $115
Total T3 thyroid hormone test
A blood test that measures the total amount of triiodothyronine (T3) hormone in your body. T3 is a thyroid hormone that helps regulate metabolism and energy levels.
13 $14 $180
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
46.5% high complexity
44.4% medium
9.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,546
Total received (2018-2024)
Avg $1,221/year across 7 years
Top 32% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
370
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,168 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$378 (4.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,020
2023
$1,678
2022
$1,004
2021
$897
2020
$83
2019
$1,549
2018
$1,316

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$303
E.R. Squibb & Sons, L.L.C.
$223
Celgene Corporation
$148
PFIZER INC.
$143
Genentech USA, Inc.
$142
Gilead Sciences, Inc.
$120
Merck Sharp & Dohme LLC
$120
Astellas Pharma US Inc
$104
Daiichi Sankyo Inc.
$100
Eisai Inc.
$71
TerSera Therapeutics LLC
$50
GlaxoSmithKline, LLC.
$47
ABBVIE INC.
$46
AstraZeneca Pharmaceuticals LP
$44
Mirati Therapeutics, Inc.
$42
Adaptive Biotechnologies Corporation
$36
Deciphera Pharmaceuticals Inc.
$26
SERVIER PHARMACEUTICALS LLC
$25
Pharmacosmos Therapeutics Inc.
$25
ImmunoGen, Inc.
$24
Agios Pharmaceuticals, Inc.
$24
Incyte Corporation
$23
Blueprint Medicines Corporation
$23
Janssen Biotech, Inc.
$21
Iovance Biotherapeutics, Inc.
$20
Tempus AI, Inc
$20
TAIHO ONCOLOGY, INC.
$18
Secura Bio, Inc.
$15
Janssen Pharmaceuticals, Inc
$15
Top 3 companies account for 33.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,003
Takeda Pharmaceuticals U.S.A., Inc.
$624
PFIZER INC.
$503
E.R. Squibb & Sons, L.L.C.
$483
AstraZeneca Pharmaceuticals LP
$429
Merck Sharp & Dohme LLC
$399
Genentech USA, Inc.
$376
Incyte Corporation
$342
Merck Sharp & Dohme Corporation
$275
ABBVIE INC.
$254
Celgene Corporation
$226
Janssen Biotech, Inc.
$225
Seagen Inc.
$213
Eisai Inc.
$197
Daiichi Sankyo Inc.
$193
Astellas Pharma US Inc
$190
Gilead Sciences, Inc.
$180
Pharmacyclics LLC, An AbbVie Company
$170
TESARO, Inc.
$153
Bayer HealthCare Pharmaceuticals Inc.
$125
GlaxoSmithKline, LLC.
$103
Puma Biotechnology, Inc.
$95
Myriad Genetic Laboratories, Inc.
$93
TerSera Therapeutics LLC
$89
SERVIER PHARMACEUTICALS LLC
$85
G1 Therapeutics, Inc.
$84
Amgen Inc.
$73
Heron Therapeutics, Inc.
$67
GENZYME CORPORATION
$66
ImmunoGen, Inc.
$65
EMD Serono, Inc.
$63
BeiGene USA, Inc.
$61
Pharmacyclics LLC, an AbbVie Company
$58
Adaptive Biotechnologies Corporation
$58
Janssen Pharmaceuticals, Inc
$58
Karyopharm Therapeutics Inc.
$46
AbbVie, Inc.
$45
Lilly USA, LLC
$45
Mirati Therapeutics, Inc.
$42
TOLMAR Pharmaceuticals, Inc.
$42
Lexicon Pharmaceuticals, Inc.
$40
Agios Pharmaceuticals, Inc.
$40
JAZZ PHARMACEUTICALS INC.
$36
NOVARTIS PHARMACEUTICALS CORPORATION
$34
AMAG Pharmaceuticals, Inc.
$33
Bayer Healthcare Pharmaceuticals Inc.
$27
Deciphera Pharmaceuticals Inc.
$26
Pharmacosmos Therapeutics Inc.
$25
Kyowa Kirin, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$25
Foundation Medicine, Inc.
$24
AbbVie Inc.
$24
MorphoSys, US Inc.
$24
Blueprint Medicines Corporation
$23
EISAI INC.
$23
Coherus Biosciences Inc.
$20
Iovance Biotherapeutics, Inc.
$20
Tempus AI, Inc
$20
AVEO Pharmaceuticals, Inc.
$19
TAIHO ONCOLOGY, INC.
$18
Dendreon Pharmaceuticals LLC
$18
MACROGENICS, INC.
$18
Janssen Scientific Affairs, LLC
$16
Alexion Pharmaceuticals, Inc.
$16
Taiho Oncology, Inc.
$15
Secura Bio, Inc.
$15
Inari Medical, Inc.
$14
PUMA BIOTECHNOLOGY, INC.
$13
Top 3 companies account for 24.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Alecensa · Amtagvi · BAVENCIO · BOSULIF · BRUKINSA · CALQUENCE · CINVANTI · COPIKTRA · COSELA · DARZALEX · DAURISMO · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · EVENITY · Elahere · EndoPredict · Enhertu · FARESTON · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FOUNDATIONONE · Fabhalta · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nplate · OPDIVO · OPDUALAG · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Revlimid · S · SCEMBLIX · SOLIRIS · SUSTOL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tecentriq · Tibsovo · Trodelvy · Udenyca · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Rolling Meadows?
Compare hematology & oncology specialists in the Rolling Meadows area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
274
Per 100K population
5.3
County median income
$81,797
Nearest hospital
NORTHWEST COMMUNITY HOSPITAL 1
1.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pandey is a mixed practice specialist, with above-average Medicare volume (top 20% in IL), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pandey experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Pandey performed 23,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pandey receive payments from pharmaceutical companies?
Yes. Dr. Pandey received a total of $8,546 from 68 companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pandey's costs compare to other hematology & oncology specialists in Rolling Meadows?
Dr. Pandey's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pandey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →